{"schema_version":"secwatch.filing_event.v1","accession":"0000049071-24-000042","form_type":"8-K","ticker":"HUM","cik":"0000049071","company_name":"HUMANA INC","filed_at":"2024-09-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.555965+00:00","generated_at":"2026-05-31T06:42:30.195613+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Humana reaffirms FY2024 guidance: GAAP EPS ~$12.81, adjusted EPS ~$16.00","bullets":["Guidance unchanged from July 31, 2024 press release; FY2024 GAAP EPS ~$12.81.","Adjusted EPS ~$16.00; adjustments include amortization $0.50, put/call $1.65, exit commercial medical $1.21, value creation $0.80, net tax -$0.97.","Management reaffirms guidance in investor meetings Sept 3-30, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0000049071-24-000042","json":"https://secwatch.observer/filing/0000049071-24-000042.json","markdown":"https://secwatch.observer/filing/0000049071-24-000042.md","text":"https://secwatch.observer/filing/0000049071-24-000042.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/49071/000004907124000042/0000049071-24-000042-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/49071/000004907124000042/hum-20240903.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T06:42:30.195613+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}